Paeds Vivas · gastroenterology-hepatology-and-nutrition
Coeliac disease — branching viva
Branching viva from the definition and pathogenesis of coeliac disease through the classic toddler, the adolescent with refractory iron deficiency, the child with type 1 diabetes, and the atypical presentation, testing the ESPGHAN 2020 no-biopsy pathway, the gluten-on-board rule and the selective immunoglobulin A deficiency trap.
On this page & tools
Target exams
Station opening
Examiner: "Define coeliac disease and outline your approach to a child referred with possible coeliac disease." [1]
Strong candidate (must-hit)
- Defines coeliac disease as a permanent, immune-mediated small-bowel enteropathy induced by dietary gluten in people who carry HLA-DQ2 or HLA-DQ8; frames the approach around recognising the classic and non-classic faces, confirming the diagnosis with immunoglobulin A anti-tissue-transglutaminase plus a total immunoglobulin A taken while the child is still eating gluten, applying the ESPGHAN 2020 no-biopsy pathway when the criteria are met, and treating with a strict lifelong gluten-free diet with monitoring; states that the gluten-on-board rule is the single most important practical principle. [1]
Weak candidate
- "Coeliac disease is an allergy to wheat, and I would test for it and start a gluten-free diet." [1]
Branch A — The classic toddler
Examiner: "An eighteen-month-old has loose pale bulky stools, a distended abdomen, irritability and failure to thrive after starting gluten. What is the diagnosis and how do you confirm it?" [2]
Strong
- Makes the diagnosis of classic coeliac disease from the steatorrhoeic stools, the distended abdomen with wasted buttocks, the irritability and the fall across the weight centiles after weaning onto gluten; confirms it with immunoglobulin A anti-tissue-transglutaminase plus a total immunoglobulin A on a gluten-containing diet, applying the no-biopsy pathway when the titre is at or above ten times the upper limit of normal with positive endomysial antibody on a separate sample, and otherwise duodenal biopsy with bulb biopsies showing villous atrophy, crypt hyperplasia and raised intraepithelial lymphocytes. [2] [1]
Weak
- "I would stop gluten and see if he improves, then test the antibodies." [1]
Branch B — The fourteen-year-old with refractory iron deficiency
Examiner: "A fourteen-year-old has iron-deficiency anaemia that has not responded to three months of oral iron, short stature and a maternal aunt with coeliac disease. She is still on a gluten diet. Her anti-tissue-transglutaminase titre is twelve times the upper limit of normal. What is your next step, and can you make the diagnosis without a biopsy?" [1]
Strong
- Sends a separate serum sample for endomysial antibody and confirms a normal total immunoglobulin A, then applies the ESPGHAN 2020 no-biopsy pathway: a symptomatic child with an anti-tissue-transglutaminase titre at or above ten times the upper limit of normal, positive endomysial antibody on a separate sample and normal total immunoglobulin A can be diagnosed with coeliac disease without duodenal biopsy, the human leukocyte antigen requirement having been dropped in 2020; explains that iron refractory to oral iron is a classic clue because iron is absorbed at the duodenal tip where the atrophy is worst. [1] [4]
Weak
- "The titre is high, so I would refer for a biopsy to be sure before doing anything else." [1]
Branch C — The eight-year-old with type 1 diabetes
Examiner: "An eight-year-old with type 1 diabetes has a positive anti-tissue-transglutaminase on routine screening but no gut symptoms. The total immunoglobulin A is normal. Do you treat, and why?" [5]
Strong
- Confirms the diagnosis, classically with a positive endomysial antibody on a separate sample and, where the no-biopsy criteria are not fully met, with duodenal biopsy; treats even though the child is asymptomatic, because untreated coeliac disease can impair growth, reduce bone density and destabilise glycaemic control; manages the gluten-free diet jointly with a dietitian who reconciles it with carbohydrate counting and insulin adjustment; and explains that the three to eight per cent prevalence of coeliac disease in type 1 diabetes is the reason for periodic screening. [5] [1]
Weak
- "She has no symptoms, so I would just watch her and retest in a few years." [5]
Branch D — The child already on a gluten-free diet
Examiner: "A family has read online that gluten is harmful and has put their six-year-old on a gluten-free diet for two months. The symptoms have improved and the coeliac serology is now negative. How do you establish whether she actually has coeliac disease?" [1]
Strong
- Explains that the negative serology is uninterpretable because the antibodies fall within weeks on a gluten-free diet; establishes the diagnosis by a formal gluten challenge, reintroducing a gluten-containing diet for several weeks and repeating the serology and, where needed, the duodenal biopsy; counsels the family that the challenge is symptom-laden and unpleasant, and that the lesson is to test before the diet is ever started. [1] [3]
Weak
- "The negative antibodies mean she does not have coeliac disease, so she can stay on the diet." [1]
Close
Examiner: "Summarise your approach to the child with suspected coeliac disease in one sentence." [1]
Strong
- "Coeliac disease is a permanent gluten-induced immune enteropathy in HLA-DQ2 or DQ8 carriers: I suspect it in any child with faltering growth, refractory iron deficiency, short stature, chronic diarrhoea or a distended abdomen, confirm it with immunoglobulin A anti-tissue-transglutaminase plus total immunoglobulin A on a gluten-containing diet, apply the ESPGHAN 2020 no-biopsy pathway when the titre is at or above ten times the upper limit of normal with positive endomysial antibody on a separate sample, and treat with a strict lifelong gluten-free diet with monitoring." [1] [5]
References
- [1]Husby S; Koletzko S; Korponay-Szabó I; Kurppa K; Mearin ML; Ribes-Koninckx C European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020 J Pediatr Gastroenterol Nutr, 2020.PMID 31568151
- [2]Hill ID; Fasano A; Guandalini S; Hoffenberg E; Levy J; Reilly N NASPGHAN Clinical Report on the Diagnosis and Treatment of Gluten-related Disorders J Pediatr Gastroenterol Nutr, 2016.PMID 27035374
- [3]Giersiepen K; Lelgemann M; Stuhldreher N; Ronfani L; Husby S; Koletzko S Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report J Pediatr Gastroenterol Nutr, 2012.PMID 22266486
- [4]Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice Gastroenterology, 2017.PMID 28624578
- [5]Mearin ML; Agardh D; Antunes H; Al-Toma A; Auricchio R; Castillejo G ESPGHAN Position Paper on Management and Follow-up of Children and Adolescents With Celiac Disease J Pediatr Gastroenterol Nutr, 2022.PMID 35758521